Dylan Beynon, CEO of Mindbloom, talks about why he started this company, the impact of Ketamine and MDMA therapy in our society, and how this industry is just going to grow bigger in the future.
TIME-STAMPED SHOW NOTES:
[00:00] – Know more about Dylan Beynon and his company, Mindbloom
[02:30] – Why did Dylan Beynon start Mindbloom
[06:22] – Dylan Beynon talks more about MDMA therapy
[13:30] – Pricing and treatment programs that Mindbloom offer
[15:30] – Dylan Beynon’s personal opinion on MDMA and Ketamine therapy
[22:12] – The largest peer review clinical study for psychedelic and ketamine therapy
[25:20] – The best mental health tool for Dylan Beynon
[27:53] – Dylan Beynon talks about Vipassana Meditation
[36:00] – Where to find Dylan Beynon and learn more about Mindbloom
Go to https://www.marketingschool.io to learn more!
Don’t forget to help us grow by subscribing and liking on YouTube!
Leave Some Feedback:
What should we talk about next? Please let us know in the comments below
Did you enjoy this episode? If so, please leave a short review.
Connect with Us:
Single Grain << Eric’s ad agency
NP Digital << Neil’s ad agency
X @neilpatel
X @ericosiu
Discover Latest Episodes
In this episode #3038, Eric Siu and Neil Patel break down agency growth and revenue trends, highlighting the effectiveness of outbound marketing in driving results. They also compare capitalism and so...
In this episode #3067, Eric and Neil discuss how content creation is shifting from keyword-heavy tactics to covering topics in depth, especially with AI reshaping SEO. They highlight the value of plat...
In this episode #3036, Eric and Neil discuss how AI is reshaping the job market, with fewer junior roles available and a growing demand for senior talent. They highlight the importance of adapting thr...